Streetbeat News

Regulatory

OPTT

Ocean Power Technologies has received a $1.1 million preliminary award from the New Jersey Economic Development Authority's Technology Business Tax Certificate Transfer Program. This award is part of a program designed to support technology companies in New Jersey.

Portfolio Pulse from Benzinga Newsdesk

October 02, 2024 | 12:16 pm

TCMD

Tactile Systems Technology, Inc. (NASDAQ:TCMD) has announced the commercial availability of Nimbl, its next-generation pneumatic compression platform, in the U.S. for treating upper extremity lymphedema. Nimbl is smaller and lighter than previous models and has received FDA clearance and CMS approval.

Portfolio Pulse from Benzinga Newsdesk

October 02, 2024 | 12:14 pm

ESTA

Establishment Labs has announced the first U.S. breast augmentations using their newly FDA-approved Motiva Implants. This marks a significant milestone for the company as it enters the U.S. market.

Portfolio Pulse from Benzinga Newsdesk

October 02, 2024 | 12:09 pm

RXRX

Recursion Pharmaceuticals has received FDA clearance for its investigational new drug application for REC-1245, a potential treatment for biomarker-enriched solid tumors and lymphoma. This development could enhance Recursion's position in the biotech industry.

Portfolio Pulse from Benzinga Newsdesk

October 02, 2024 | 12:02 pm

ZEPP

Zepp Health Corporation has regained compliance with the NYSE's minimum share price requirement, ensuring its continued listing on the exchange.

Portfolio Pulse from Benzinga Newsdesk

October 02, 2024 | 11:01 am

HUM

Humana is exploring options to address a potential revenue decline in 2026 due to a drop in its 2025 Medicare Advantage Star Ratings. The percentage of members in plans rated 4 stars or above has decreased significantly, impacting future quality bonus payments.

Portfolio Pulse from Benzinga Newsdesk

October 02, 2024 | 10:48 am

GNTA

Genenta Science has received approval from the Agenzia Italiana del Farmaco for a new Phase 1 trial of its flagship product, Temferon, targeting metastatic renal cell cancer.

Portfolio Pulse from Benzinga Newsdesk

October 02, 2024 | 10:33 am

GOOGL

SNAP

The EU Commission has sent requests for information to YouTube, Snapchat, and TikTok regarding their recommender systems under the Digital Services Act. This move is part of the EU's efforts to ensure compliance with new digital regulations.

Portfolio Pulse from Benzinga Newsdesk

October 02, 2024 | 10:12 am

EWU

A Bank of England survey reveals that a record number of banks view geopolitical tensions as the top risk. The survey also highlights concerns about a potential sharp correction in equity and other markets.

Portfolio Pulse from Benzinga Newsdesk

October 02, 2024 | 9:33 am